These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31160688)

  • 41.
    Santoro AL; Drummond RD; Silva IT; Ferreira SS; Juliano L; Vendramini PH; Lemos MBDC; Eberlin MN; Andrade VP
    Cancer Res; 2020 Mar; 80(6):1246-1257. PubMed ID: 31911556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolically Active Zones Involving Fatty Acid Elongation Delineated by DESI-MSI Correlate with Pathological and Prognostic Features of Colorectal Cancer.
    Kaufmann M; Iaboni N; Jamzad A; Hurlbut D; Ren KYM; Rudan JF; Mousavi P; Fichtinger G; Varma S; Caycedo-Marulanda A; Nicol CJB
    Metabolites; 2023 Mar; 13(4):. PubMed ID: 37110166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.
    Kelly RS; Vander Heiden MG; Giovannucci E; Mucci LA
    Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):887-906. PubMed ID: 27197278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.
    Tong Q; Zhang C; Tu Y; Chen J; Li Q; Zeng Z; Wang F; Sun L; Huang D; Li M; Qiu S; Chen W
    Talanta; 2022 Feb; 238(Pt 2):123045. PubMed ID: 34801902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced capabilities for imaging gangliosides in murine brain with matrix-assisted laser desorption/ionization and desorption electrospray ionization mass spectrometry coupled to ion mobility separation.
    Škrášková K; Claude E; Jones EA; Towers M; Ellis SR; Heeren RM
    Methods; 2016 Jul; 104():69-78. PubMed ID: 26922843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue distribution and metabolic profiling of cyclosporine (CsA) in mouse and rat investigated by DESI and MALDI mass spectrometry imaging (MSI) of whole-body and single organ cryo-sections.
    Holm NB; Deryabina M; Knudsen CB; Janfelt C
    Anal Bioanal Chem; 2022 Oct; 414(24):7167-7177. PubMed ID: 35953725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Untargeted Metabolomic Profile for the Detection of Prostate Carcinoma-Preliminary Results from PARAFAC2 and PLS-DA Models.
    Amante E; Salomone A; Alladio E; Vincenti M; Porpiglia F; Bro R
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31443574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of metabolomics to prostate cancer.
    Trock BJ
    Urol Oncol; 2011; 29(5):572-81. PubMed ID: 21930089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status.
    Dudka I; Thysell E; Lundquist K; Antti H; Iglesias-Gato D; Flores-Morales A; Bergh A; Wikström P; Gröbner G
    BMC Cancer; 2020 May; 20(1):437. PubMed ID: 32423389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review.
    Bansal N; Kumar M; Sankhwar SN; Gupta A
    Expert Rev Mol Med; 2022 Jun; 24():e25. PubMed ID: 35730322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue.
    Vandergrift LA; Decelle EA; Kurth J; Wu S; Fuss TL; DeFeo EM; Halpern EF; Taupitz M; McDougal WS; Olumi AF; Wu CL; Cheng LL
    Sci Rep; 2018 Mar; 8(1):4997. PubMed ID: 29581441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
    Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
    J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies.
    DeHoog RJ; Zhang J; Alore E; Lin JQ; Yu W; Woody S; Almendariz C; Lin M; Engelsman AF; Sidhu SB; Tibshirani R; Suliburk J; Eberlin LS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21401-21408. PubMed ID: 31591199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatially Resolved Metabolomics Method for Mapping the Global Molecular Landscape of Whole-Body Zebrafish (
    Sun Y; Zhou Z; Xie B; Wang Z; Abliz Z
    Anal Chem; 2023 Jun; 95(24):9164-9172. PubMed ID: 37264941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.
    Andras I; Crisan N; Vesa S; Rahota R; Romanciuc F; Lazar A; Socaciu C; Matei DV; de Cobelli O; Bocsan IS; Coman RT
    Future Oncol; 2017 Aug; 13(20):1793-1800. PubMed ID: 28776421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue.
    Andersen MK; Krossa S; Høiem TS; Buchholz R; Claes BSR; Balluff B; Ellis SR; Richardsen E; Bertilsson H; Heeren RMA; Bathen TF; Karst U; Giskeødegård GF; Tessem MB
    Anal Chem; 2020 Feb; 92(4):3171-3179. PubMed ID: 31944670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry.
    Eberlin LS; Dill AL; Costa AB; Ifa DR; Cheng L; Masterson T; Koch M; Ratliff TL; Cooks RG
    Anal Chem; 2010 May; 82(9):3430-4. PubMed ID: 20373810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adequate histologic sectioning of prostate needle biopsies.
    Bostwick DG; Kahane H
    Ann Diagn Pathol; 2013 Aug; 17(4):357-60. PubMed ID: 23764163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of metabolic imaging in radiation therapy of prostate cancer.
    Zhang VY; Westphalen A; Delos Santos L; Tabatabai ZL; Shinohara K; Vigneron DB; Kurhanewicz J
    NMR Biomed; 2014 Jan; 27(1):100-11. PubMed ID: 23940096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.